These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7545917)

  • 1. A peptide derived from the amino terminus of endothelial-monocyte-activating polypeptide II modulates mononuclear and polymorphonuclear leukocyte functions, defines an apparently novel cellular interaction site, and induces an acute inflammatory response.
    Kao J; Fan YG; Haehnel I; Brett J; Greenberg S; Clauss M; Kayton M; Houck K; Kisiel W; Seljelid R
    J Biol Chem; 1994 Apr; 269(13):9774-82. PubMed ID: 7545917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel tumor-derived cytokine. Endothelial-monocyte activating polypeptide II.
    Kao J; Houck K; Fan Y; Haehnel I; Libutti SK; Kayton ML; Grikscheit T; Chabot J; Nowygrod R; Greenberg S
    J Biol Chem; 1994 Oct; 269(40):25106-19. PubMed ID: 7929199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial monocyte-activating polypeptide II. A novel tumor-derived polypeptide that activates host-response mechanisms.
    Kao J; Ryan J; Brett G; Chen J; Shen H; Fan YG; Godman G; Familletti PC; Wang F; Pan YC
    J Biol Chem; 1992 Oct; 267(28):20239-47. PubMed ID: 1400342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial-monocyte-activating polypeptide II.
    Tas MP; Murray JC
    Int J Biochem Cell Biol; 1996 Aug; 28(8):837-41. PubMed ID: 8811833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N terminus of pro-endothelial monocyte-activating polypeptide II (EMAP II) regulates its binding with the C terminus, arginyl-tRNA synthetase, and neurofilament light protein.
    Xu H; Malinin NL; Awasthi N; Schwarz RE; Schwarz MA
    J Biol Chem; 2015 Apr; 290(15):9753-66. PubMed ID: 25724651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of endothelial monocyte-activating polypeptide II in the rat dental follicle and its potential role in tooth eruption.
    Liu D; Wise GE
    Eur J Oral Sci; 2008 Aug; 116(4):334-40. PubMed ID: 18705801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer cells induce lymphocyte apoptosis by an endothelial monocyte-activating polypeptide-II-dependent mechanism.
    Murray JC; Symonds P; Ward W; Huggins M; Tiga A; Rice K; Heng YM; Todd I; Robins RA
    J Immunol; 2004 Jan; 172(1):274-81. PubMed ID: 14688335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase. Its functional implication in endothelial cell proliferation.
    Chang SY; Park SG; Kim S; Kang CY
    J Biol Chem; 2002 Mar; 277(10):8388-94. PubMed ID: 11741979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial monocyte-activating polypeptide-II (EMAP-II): a novel inducer of lymphocyte apoptosis.
    Murray JC; Heng YM; Symonds P; Rice K; Ward W; Huggins M; Todd I; Robins RA
    J Leukoc Biol; 2004 May; 75(5):772-6. PubMed ID: 14982944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of endothelial-monocyte-activating polypeptide-II expression in vivo.
    Murray JC; Barnett G; Tas M; Jakobsen A; Brown J; Powe D; Clelland C
    Am J Pathol; 2000 Dec; 157(6):2045-53. PubMed ID: 11106577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour necrosis factor receptor I (p55) is upregulated on endothelial cells by exposure to the tumour-derived cytokine endothelial monocyte- activating polypeptide II (EMAP-II).
    Berger AC; Alexander HR; Wu PC; Tang G; Gnant MF; Mixon A; Turner ES; Libutti SK
    Cytokine; 2000 Jul; 12(7):992-1000. PubMed ID: 10880244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-surface associated p43/endothelial-monocyte-activating-polypeptide-II in hepatocellular carcinoma cells induces apoptosis in T-lymphocytes.
    Faisal W; Symonds P; Panjwani S; Heng Y; Murray JC
    Asian J Surg; 2007 Jan; 30(1):13-22. PubMed ID: 17337366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
    Li Z; Liu YH; Xue YX; Liu LB; Wang P
    J Mol Neurosci; 2012 Sep; 48(1):291-301. PubMed ID: 22531886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial-monocyte-activating polypeptide II induces migration of endothelial progenitor cells via the chemokine receptor CXCR3.
    Hou Y; Plett PA; Ingram DA; Rajashekhar G; Orschell CM; Yoder MC; March KL; Clauss M
    Exp Hematol; 2006 Aug; 34(8):1125-32. PubMed ID: 16863920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic damage of tumor vessels with ultra low-dose endothelial-monocyte activating polypeptide-II and neovasculature-targeted tumor necrosis factor-alpha.
    Crippa L; Gasparri A; Sacchi A; Ferrero E; Curnis F; Corti A
    Cancer Res; 2008 Feb; 68(4):1154-61. PubMed ID: 18281491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ΞΆ/PP2A-dependent signaling mechanism.
    Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB
    Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.
    Clauss M; Gerlach M; Gerlach H; Brett J; Wang F; Familletti PC; Pan YC; Olander JV; Connolly DT; Stern D
    J Exp Med; 1990 Dec; 172(6):1535-45. PubMed ID: 2258694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial monocyte activating polypeptide II (EMAP II) enhances the effect of TNF on tumor-associated vasculature.
    Kayton ML; Libutti SK
    Curr Opin Investig Drugs; 2001 Jan; 2(1):136-8. PubMed ID: 11527006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly differentiated motifs responsible for two cytokine activities of a split human tRNA synthetase.
    Wakasugi K; Schimmel P
    J Biol Chem; 1999 Aug; 274(33):23155-9. PubMed ID: 10438485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate regulates the antiangiogenic activity of endothelial monocyte-activating polypeptide-II at acidic pH.
    Chang SY; Ko HJ; Heo TH; Kang CY
    Mol Pharmacol; 2005 May; 67(5):1534-43. PubMed ID: 15710745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.